MA
Profile Overview
Matt Angel appears in the TWiST corpus as the Paradromics co-founder pushing high-bandwidth brain-computer interfaces toward clinical reality. In E2263, the conversation centers on therapeutic use cases first, especially restoring communication and motor function, and on the technical importance of signal quality close to the brain.
What the episodes support
- Paradromics is focused on high-density brain-computer interfaces aimed at restoring speech and motor function in clinical settings.
- The company's wedge is better signal capture and decoding, not just consumer hype around implants.
- The episode frames Paradromics as pursuing therapeutic applications before broader enhancement narratives.
Evidence in the corpus
- The episode summary explicitly describes Paradromics moving toward human clinical trials for restoring speech and motor function.
- The discussion highlights the contrast between BCI approaches and emphasizes signal resolution and data throughput as core technical differentiators.
Source discipline
This profile is constrained to claims grounded in the episode and linked entity pages. No speculative biography, no invented operating history, and no unsourced praise.
Appearance history
E2263Are Brain-Computer Interfaces Actually Ready for Humans?